SYK Stock Analysis: Buy, Sell, or Hold?
SYK - Stryker Corporation
$369.56
15.26 (4.31%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Apr 29, 2026
Get Alerted When SYK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called SYK this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SYK shows positive signals but monitor for confirmation. Market pricing in 0.5% decline. Moderate conviction.
💡 BUY OPPORTUNITY: SYK shows positive signals but monitor for confirmation. Market pricing in 0.5% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$506.90
Based on 7.1% avg growth
INTRINSIC VALUE TODAY
$314.74
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 24.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SYK is currently trading at $369.56, which is considered extended relative to its 30-day fair value range of $352.56 to $364.19. The stock's valuation (Forward PE: 23.7) is in line with its historical norms (24.1). Remarkably, the market is currently pricing in an annual earnings decline of 0.5% over the next few years. This pessimistic expectation contrasts with the company's recent 2.8% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, SYK is in a downtrend. The price is approaching resistance at $369.10. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.3% recently.
Market Sentiment: SYK has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $425.68 (+20.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SYK is in a downtrend. The price is approaching resistance at $369.10. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.3% recently.
Market Sentiment: SYK has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $425.68 (+20.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$352.56 -
$364.19
Company Quality Score
68/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.3%)
- BULLISH: Trading 20.1% below Wall St target ($425.68)
Fair Price Analysis
30-Day Fair Range
$352.56 -
$364.19
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$350.32
Resistance Level
$369.10
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
23.71
Wall Street Target
$425.68
(+20.1%)
Revenue Growth (YoY)
10.2%
Earnings Growth (YoY)
2.8%
Profit Margin
12.1%
Valuation Discount vs History
-0.5% cheaper
PE vs Historical
23.7 vs 24.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.5%
(market-implied from PE analysis)
1-Year Target
$352.53
(-1%)
2-Year Target
$350.77
(-1%)
3-Year Target
$349.01
(-2%)
3-Yr Target (if PE normalizes)
(PE: 24→24)
$354.73
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.7, Growth: 10.2%)
$474.30
(+34%)
Base:
(SPY PE: 22.3, Growth: 10.2%)
$446.06
(+26%)
Bear:
(PE: 19.0, Growth: 10.2%)
$379.15
(+7%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (47x PE), but valuation improves significantly next year (24x PE) as earnings recover.
Trailing PE: 46.96 | Current EPS (TTM): $7.62
Bull Case
$771.83
(+109%)
Analyst growth 96.1%, PE expands to 51.7
Base Case
$701.67
(+90%)
Market implied 96.1%, PE stable at 47.0
Bear Case
$243.32
(-34%)
Severe decline -20.0%, PE contracts to 39.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 23.7 to 24.1
Stabilization Target:
$360.10
(+1.6%)
PE Expansion Potential:
+1.6%
Last updated: January 31, 2026 1:08 AM ET
Data refreshes hourly during market hours. Next update: 2:08 AM
Data refreshes hourly during market hours. Next update: 2:08 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SYK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Thomas H. Kean, Jr.
SELL
2025-09-12
Viju Menon
SELL
500 shares
2025-08-25
Thomas H. Kean, Jr.
SELL
2025-08-25
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$136 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$374 | 54 HOLD |
Advanced SYK Option Strategies
Professional options setups generated by AI based on today's SYK price and gamma walls.
